Walgreens Boots Alliance (NASDAQ:WBA) Announces Earnings Results

Walgreens Boots Alliance (NASDAQ:WBA) issued its earnings results on Thursday. The pharmacy operator reported $1.68 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.22 by $0.46, MarketWatch Earnings reports. Walgreens Boots Alliance had a net margin of 1.85% and a return on equity of 20.76%. The business had revenue of $33.90 billion for the quarter, compared to analysts’ expectations of $32.87 billion. During the same quarter in the previous year, the firm posted $1.22 EPS. The business’s revenue for the quarter was down 6.6% compared to the same quarter last year.

WBA stock opened at $52.44 on Friday. Walgreens Boots Alliance has a 12 month low of $43.11 and a 12 month high of $57.05. The company has a current ratio of 0.72, a quick ratio of 0.35 and a debt-to-equity ratio of 0.32. The company has a 50-day moving average price of $49.00 and a 200 day moving average price of $48.70. The stock has a market cap of $45.39 billion, a PE ratio of 17.90, a P/E/G ratio of 2.40 and a beta of 0.55.

The company also recently declared a quarterly dividend, which was paid on Friday, December 10th. Investors of record on Monday, November 15th were paid a dividend of $0.477 per share. The ex-dividend date was Friday, November 12th. This represents a $1.91 dividend on an annualized basis and a dividend yield of 3.64%. Walgreens Boots Alliance’s dividend payout ratio is presently 65.19%.

A number of research analysts have recently commented on the stock. UBS Group boosted their price target on shares of Walgreens Boots Alliance from $50.00 to $52.00 and gave the company a “neutral” rating in a research report on Wednesday, December 22nd. Truist upped their target price on shares of Walgreens Boots Alliance from $52.00 to $56.00 and gave the stock a “hold” rating in a research report on Friday, October 15th. Zacks Investment Research upgraded shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating and set a $56.00 target price for the company in a research report on Tuesday. Truist Securities upped their target price on shares of Walgreens Boots Alliance from $52.00 to $56.00 and gave the stock a “hold” rating in a research report on Friday, October 15th. Finally, Morgan Stanley lowered shares of Walgreens Boots Alliance from an “equal weight” rating to an “underweight” rating and cut their target price for the stock from $56.00 to $49.00 in a research report on Thursday, December 16th. One investment analyst has rated the stock with a sell rating, eleven have given a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $54.50.

In related news, Director Nancy M. Schlichting sold 2,725 shares of Walgreens Boots Alliance stock in a transaction dated Friday, November 19th. The shares were sold at an average price of $47.16, for a total transaction of $128,511.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 17.40% of the stock is currently owned by insiders.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc engages in the provision of drug store services. It operates through the following segments: Retail Pharmacy USA and Retail Pharmacy International. The Retail Pharmacy USA segment consists of the Walgreens business, which includes the operation of retail drugstores, health and wellness services, and mail and central specialty pharmacy services.

Featured Article: 12b-1 Fees

Earnings History for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.